[Proceedings: Recovery rate in Basedow's disease treated with thyroid antagonists: frequency of development of suppression 1 year after the initiation of the treatment].
D013956:Antithyroid Agents / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006111:Graves Disease / Q000188:drug therapy*; D006801:Humans; D014284:Triiodothyronine
D013956:Antithyroid Agents; D014284:Triiodothyronine